Rationale and Design for Shiga Microalbuminuria Reduction Trial
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00202618|
Recruitment Status : Unknown
Verified July 2005 by Shiga University.
Recruitment status was: Recruiting
First Posted : September 20, 2005
Last Update Posted : April 27, 2006
Information provided by:
Results Submitted - Not Posted on ClinicalTrials.gov
Results information has been submitted to ClinicalTrials.gov by the sponsor or investigator, but is not yet publicly available (or "posted") on ClinicalTrials.gov. The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
|Recruitment Status :||Unknown|
|Primary Completion Date :||No date given|
|Study Completion Date :||June 2006|
|Submission Cycle||Results Submitted to ClinicalTrials.gov||Results Returned after Quality Control Review|
October 23, 2011 ||November 29, 2011|
January 10, 2012 ||February 9, 2012|
March 15, 2012 ||April 9, 2012|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Shiga Microalbuminuria Reduction Trial (SMART) Group, Uzu T, Sawaguchi M, Maegawa H, Kashiwagi A. Impact of renin-angiotensin system inhibition on microalbuminuria in type 2 diabetes: a post hoc analysis of the Shiga Microalbuminuria Reduction Trial (SMART). Hypertens Res. 2008 Jun;31(6):1171-6. doi: 10.1291/hypres.31.1171. Retraction in: Hypertens Res. 2014 Jun;37(6):598.
Retraction in: Hypertens Res. 2014 Jun;37(6):598